Gene Query: ZFAT

Dataset Description Geneva Score
RNA-sequencing analysis of CD4 T cells following ipilimumab therapy 158.96
Next Generation Sequencing of isolated EGFR+ and HLA-G+ first trimester human trophoblasts 84.22
Induction and Therapeutic Targeting of Human NPM1c+ Myeloid Leukemia in the Presence of Autologous Immune System in Mice 82.44
Human interleukin-4 treated regulatory macrophages promote epithelial wound healing and reduce colitis in an mouse model 39.42
Transcriptional profiles of human blood dendritic cell (DC) subsets at steady state 39.29
CRIG identifies a novel population of highly phagocytic peritoneal macrophages associated with disease severity in patients with cirrhosis and ascites 30.71
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies 28.03
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies [RNA-Seq] 28.03
Stimulation of isolated plasmacytoid dendritic cells (pDCs) with TLR9 agonist CpG C (CpG) and TLR7 agonist imiquimod (IMQ) 24.63
Transcriptome analysis of virus infected tissues 23.87
Effect of Hypoxia in Severe Preeclampsia through Epigenetic Regulation 21.18
Intrinsic histone acetyltransferase activity of BRD4 is responsible for nucleosome eviction and transcriptional activation 17.25
RNA-seq analysis of activated plasmacytoid dendritic cell subsets after viral infection 15.11
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [HCT RNA-Seq] 13.96
Genome-wide analysis of STAT3 in diffuse large B-cell lymphoma 12.79
Transcriptome analysis of human reninomas as an approach to understanding juxtaglomerular cell biology 12.66
Characterization of sperm lncRNA and its differently expression in the sperm of asthenozoospermic patients 12.4
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics (RNA-Seq) 12.11
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics 12.11
A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity 11.46
m6A level and isoform characterization sequencing (m6A-LAIC-seq) reveal the census and complexity of the m6A epitranscriptome 9.75
SnapShot-Seq: a method for extracting genome-wide, in vivo mRNA dynamics from a single total RNA sample 9.67
Salmonella activation of STAT3 signaling by SarA effector promotes intracellular replication and production of IL-10 9.53
Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial Cellular Indexing [RNA-seq] 9.38
Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial Cellular Indexing 9.38
Landscape of H3K4me3 in human CD19 cells 8.74
Primary human trophoblast from term placenta 8.74
The role of antigen presenting cells in the induction of HIV-1 latency in resting CD4+ T-cells 8.73
Stably-paused genes revealed through inhibition of transcription initiation by the TFIIH inhibitor Triptolide 8.39
Effect of ROQUIN2(Y691F) expression on mRNA levels upon BCR stimulation 8.2
Global analysis of alternative splicing regulated by RBM10 7.64
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (nuclear RNA) 7.61
Genome-wide identification of cancer-specific alternative splicing in circRNA 7.49
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 [stranded] 7.23
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma 7.13
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma (RNA-Seq) 7.13
Transcription differences in DLBCL cell lines U2932, DOHH2 on treatment with TK compound compared to DMSO 6.83
A high-throughput screening strategy identifies regulators of alternative splicing via interaction with RNA G-quadruplexes 6.69
The evolution of N6-methyladenosine in primates 6.36
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease 6.17
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease (human) 6.17
Expression data for hiPSC-derived RPE treated with 10mM Nicotinamide or vehicle 5.26
ENPP1 Mutation Causes Recessive Cole Disease by Altering Melanogenesis 5.16
Study functions of ADAR proteins using next generation sequencing of genome and transcriptome 5.08
Capturing the Interactome of Newly Transcribed RNA 5.04
Capturing the Interactome of Newly Transcribed RNA (RICK) 5.04
m6A-RNA mapping, SND1-RNA binding profile mapping and SND1-depletion in KSHV-infected B-lymphocytes 4.93
The serine hydroxymethyltransferase-2 (SHMT2) initiates lymphoma development through epigenetic tumor suppressor silencing. 4.61
Gene expression profiling in follicular lymphoma (FL) samples and paired transformed follicular lymphoma (tFL) (n=6 samples) 4.61
Ro60-knockout cells 4.6
CRISPR/Cas9 Screens Reveal Epstein-Barr virus Synthetic Lethal Targets 4.47
Persistence of stem cell metabolism in cancers as a failure of differentiation 4.47
The comparison of high-throughput single-cell RNA-seq methods 4.29
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 4.23
RNA-Seq of LRRK2 G2019S Parkinson’s iPSC-derived astrocytes 4.08
RNA-seq in HT-29 colorectal cancer cells after F. nucleatum treatment 3.93
Identification of novel recurrent ETV6-IGH fusions in primary central nervous system lymphoma using high throughput RNA sequencing 3.89
Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors 3.87
RNA-sequencing of bulk CD19+ Thymic B cells from mice and humans 3.77
RNA-sequencing of bulk CD19+ Thymic B cells from young (3 month - 4 year) and old (42 - 61 years) humans 3.77
Allelic expression mapping across cell lineages reveal repressor disruption among disease SNPs 3.74
Overexpression of UGT2B17 in MEC1 and JVM2 leukemia cell lines 3.7
Conserved roles for murine mDUX and human DUX4 in activating cleavage stage genes and MERVL/HERVL retrotransposons [RNA-Seq] 3.61
Widespread intronic polyadenylation diversifies immune cell transcriptomes 3.49
Human Cactin interacts with DHX8 and SRRM2 to assure efficient pre-mRNA splicing and sister chromatid cohesion. 3.48
Improved LCL to iPSC reprogramming: RNA Analysis of LCLs, reprogrammed iPSCs, and differentiated NSCs reveal potential regulatory and functional processes involved in these cellular transitions. 3.19
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis 3.15
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis [RNA-seq] 3.15
Therapeutic targeting of GCB- and ABC-DLBCLs by rationally designed BCL6 inhibitors 3.15
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression 3.12
Human naïve pluripotent stem cells exhibit X chromosome dampening and X-inactivation (RNA-Seq) 3.04
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma (RNA-Seq) 3.0
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma 3.0
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [MB157_RNA-seq] 2.99
Oncolytic reactivation of KSHV as a therapeutic approach for primary effusion lymphoma: RNA-sequencing of PEL cell lines during KSHV reactivation 2.96
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 2.93
Limiting cholesterol biosynthetic flux engages type I IFN signaling in a STING-dependent manner 2.91
Heterogeneous nuclear ribonucleoprotein C1/C2 links transcriptional and splicing actions of 1,25-dihydroxyvitamin D 2.7
Gastrointestinal Stromal Tumor Enhancers Support a Transcription Factor Network Predictive of Clinical Outcome 2.54
Gastrointestinal Stromal Tumor Enhancers Support a Transcription Factor Network Predictive of Clinical Outcome 2.54
Gene expression profiling of human CD19+ B cells and EBV transformed lymphoblastoid cell lines (LCLs) 2.53
RNA-seq of exosomes identifies lncRNA profiles that distinguish early-stage esophageal squamous cell carcinoma (ESCC) from non-malignant esophagitis 2.52
Evaluation of the effectiveness of semen collection and sperm purification methods for spermatozoa transcript profiling 2.39
Differences in miRNA Detection Levels are Technology and Sequence Dependent [NGS] 2.36
Differences in miRNA Detection Levels are Technology and Sequence Dependent 2.36
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons [RNA-Seq] 2.31
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons 2.31
The Human Testis Cell Atlas via Single-cell RNA-seq (Healthy men scRNA-seq data set) 2.27
SMUG1 promotes telomere maintenance through telomerase RNA end-processing 2.26
RNA-Seq with and without RNase treatment in PCa cell lines 2.17
Deep RNA sequencing of the human placental transcriptome 2.16
The pause-initiation limit restricts transcription activation in human cells 2.15
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 2.14
U1 snRNP telescripting regulates size-function stratified human genome 2.0
Genomic profiling of human spermatogonial stem cells [BulkRNA-Seq] 1.95
Gene expression in PANC1 cells treated with Rakicidin 1.91
Transcriptome analysis of immature and matured human oocytes from patients of young and advanced maternal age 1.9
Landscape and variation of RNA secondary structure across the human transcriptome 1.85
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing (RNA-seq) 1.85
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing 1.85
The Genetic Landscape of Diamond-Blackfan Anemia 1.83
Molecular Hallmarks of Experimentally Acquired Immunity to Malaria [Pilot Study] 1.82
Molecular analysis of renal cell carcinoma with unclassfied histology [gene expression] 1.74
Molecular analysis of renal cell carcinoma with unclassfied histology 1.74
Transcriptional profiles of normal human mature B cells 1.72
Gene expression profiles of rescue with wild type or SUMO double mutant TRIM24 1.71
RNA sequencing with KSHV infection and enrichment for circular RNAs 1.7
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (chromatin-bound RNA-seq) 1.69
ILF2 Regulates RNA Splicing of DNA Damage Response Genes to Confer Poor Prognosis in 1q21-Amplified Multiple Myeloma 1.68
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis [bulk RNA-Seq] 1.63
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis 1.63
Gene expression analysis of BRD4 knockdown in HT-29 and HCT116 cells 1.61
Gene expression profile difference among renal location in a stone former 1.6
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes 1.6
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes (RNA-Seq) 1.6
RB tumor suppressor promotes cancer immunity through downregulating PD-L1 expression 1.59
Response of HEK293 Freestyle cells to 36 h of culture in Zn(II)-depleted Freestyle medium 1.59
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (BGI12 RNA-Seq) 1.57
A potent and selective small-molecule degrader of STAT3 achieves complete tumor regression in vivo 1.56
MeRIP-seq for heat shock in B-cell lymphoma cells 1.54
Genes regulated by soluble guanylyl cyclase in VCaP prostate cancer cells 1.49
MHC Transcriptomic landscape at haplotype-specific resolution 1.47
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-seq of KLF6 KO) 1.47
Glutaminolysis is a metabolic dependency in FLT3 ITD Acute Myeloid Leukemia unmasked by FLT3 Tyrosine Kinase Inhibition 1.47
Identification and validation of differentially expressed transcripts by RNA-Sequencing of formalin-fixed, paraffin-embedded (FFPE) lung tissue from patients with Idiopathic Pulmonary Fibrosis 1.46
High throughput characterization of the m6A demethylase FTO by CLIP and RNAseq 1.46
Lyophilized human cells stored at room temperature preserve multiple RNA species at excellent quality for RNA sequencing 1.44
SHQ1 regulation of RNA splicing is required for T-lymphoblastic leukemia cell survival 1.44
Gene expression profiles of brain endothelial cells during embryonic development at bulk and single-cell levels 1.42
Expression data from human perivascular stem cell-derived extracellular vesicles (PSC-EVs) and PSCs 1.42
The effects of U1 snRNA mutation in chronic lymphocytic leukemia cell lines 1.41
mRNA and RNC-mRNA deep sequencing of three hepatocellular carcinoma cell lines 1.41
Be1 and Be2 B cells are transcriptionally distinct 1.39
Human Long Intergenic Noncoding RNA Linc-ADAL Knockdown in Mature Adipocytes using Lentiviral ShRNA 1.38
Transcriptomics profiling of Alzheimer’s disease reveal novel molecular targets 1.37
Effect of drugs on transcriptomic profiles 1.34
Genetic-to-epigenetic Therapy for Pancreatic Cancer 1.3
RNA-seq data of small cell carcinoma of the bladder (SCCB) /urothelial carcinoma (Non-SCCB) clinical samples, and bladder-PARCB cell lines 1.3
Gene expression analysis of the impact of TDP-43 knockout in human cells. 1.3
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 1.28
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 1.28
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation 1.28
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation [RNA-Seq] 1.28
NRDE2 negatively regulates nuclear exosome functions 1.27
The translation termination factor GSPT1 is a phenotypically relevant off-target of heterobifunctional phthalimide degraders 1.26
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference 1.25
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference [RNA-Seq] 1.25
Whole genome analysis of the methylome and hydroxymethylome in normal and malignant lung and liver [RNA-Seq] 1.23
Whole genome analysis of the methylome and hydroxymethylome in normal and malignant lung and liver 1.23
RNA-seq of H1299 cells in which either PRKCI or SOX2 was silenced by validated lentiviral shRNA constructs 1.22
The BCL6 RD2 domain governs commitment of activated B-cells to form germinal centers 1.22
Single-cell analysis reveals stochastic regulation of type I IFN production by plasmacytoid dendritic cells and identifies host-derived environmental cues as amplifier of type I IFN production 1.22
mRNA sequencing identifies differential gene expresssion profiles between ASCC3 knock-down cells and control cells 1.21
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells 1.21
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells [RNA-seq] 1.21
Effect of ER stress on MUC1 kidney disease patient derived cells and and treatment by BRD4780 1.21
Transcriptome analysis in a radiosensitive and a radioresistant cell line after ionizing radiation 1.2
In vivo generation of post-infarct human cardiac muscle by laminin-promoted cardiovascular progenitors [LN-521 or LN-521+LN-221] 1.2
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process 1.19
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process (RNA-seq) 1.19
Diverse Compounds from Pleuromutilin Lead to a Thioredoxin Inhibitor and Inducer of Ferroptosis 1.19
Transcriptomic analysis of healthy donor and Sickle Cell Disease (SCD) hematopoietic stem/progenitor cells 1.19
Effects of Polybrominated Diphenyl Ether (PBDE) Mixture on estrogen receptor positive (ER+) patient-derived tumor xenograft (PDX) model 1.18
Expression patterns in chronic thromboembolic pulmonary hypertension 1.18
Genome-wide chromatin analysis of Ewing sarcoma (RNA-seq) 1.18
Genome-wide chromatin analysis of Ewing sarcoma 1.18
Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation 1.17
Tristetraprolin disables prostate cancer maintenance by impairing proliferation and metabolic function 1.17
Effects of transcription factor CEBPA knockdown on vitamin D target gene regulation in THP-1 cells 1.17
The pioneer factor CEBPA modulates vitamin D signaling 1.17
RNA-sequencing of milk cells extracted from pre-partum secretions and longitudinally from mature human milk across the first year of lactation 1.15
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia 1.14
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia (RNA-seq) 1.14
Transcriptome analysis in HT29 and SW480 cells depleted of Prdx2 1.14
Effect of REST on cancer invasiveness in MCF-7 and MDA-MB-231 cells using RNA-sequencing (RNA-seq) analysis . 1.13
ADAR1 controls apoptosis of stressed cells by inhibiting Staufen-mediated mRNA decay 1.11
CpG dinucleotides introduced into gag can inhibit HIV-1 gene expression by modulating pre-mRNA splicing 1.1
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 1.08
Estrogen deprivation triggers and immunosuppressive phenotype in breast cancer cells 1.06
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [ChrRNA-seq] 1.06
p38 SAPK and SKIIP induced changes in alternative splicing patterns upon osmostress 1.05
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 1.02
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 1.02
MLL-AF4 binds directly to a BCL-2 specific enhancer and impacts H3K27 acetylation 1.0
RNA-Seq and ChIP-Seq reveals SQSTM1/p62 as a key mediator of JunB suppression of NF-kB-dependent inflammation 0.98
JunB control of keratinocyte-mediated inflammation [RNA-seq] 0.98
Splicing and gene expression changes in human MDAM-MB231 breast cancer cells with TRA2B knockdown 0.98
Primate transcript and protein expression levels evolve under compensatory selection pressures 0.98
MYC dependent mRNA translation shapes gene expression and cell biology 0.97
polyA RNA Sequencing Analysis of HTR-8/SVneo cells after lnc-SLC4A1-1 overexpression 0.97
MYC interacts with the G9a histone methyltransferase to drive transcriptional repression and tumorigenesis 0.97
RNA-Seq and expression data from human adipose tissue 0.96
Tissue-specific RNA-seq in human evoked inflammation identifies novel blood and adipose lincRNA signatures of cardio-metabolic diseases 0.96
RNA profiling Analysis of the Serum Exosomes Derived from Active and Latent M.tuberculosis infectious Patients 0.96
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells 0.94
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation 0.93
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation [bulk RNA-Seq] 0.93
IQGAP3 interacts with Rad17 to activate the MRN/ATM/Chk2 signaling and promote radioresistance in lung cancer 0.92
DHX36 is the missing link to understand RNA G-quadruplex structures, mRNA stability, and translation [RNA-seq] 0.92
A role for ZNF598 in post-transcriptional gene regulation 0.92
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation 0.92
Genome-Wide Transcriptional Effects of the Anti-Cancer Agent Camptothecin 0.91
Alu RNA modulates the expression of cell cycle genes in human fibroblasts 0.91
Next Generation Sequencing of control (Untreated), PAN injured and Adriamycin injured human podocytes 0.9
Acetyl-CoA carboxylase inhibition regulates microtubule dynamics and intracellular transport in cystic fibrosis epithelial cells 0.9
Identification of PRMT5-dependent genes in ESA+CD24lowCD44+ MCF7 cells 0.9
RNA-sequencing of the human milk fat layer during colostrum, transitional, and mature stages of lactation 0.9
Widespread Transcription beyond mRNA 3’ Ends Yields Abundant Regulatory RNAs 0.88
Combined use of astragalus polysaccharide and berberine attenuates insulin resistance in IR-HepG2 cells via regulation of the gluconeogenesis signaling pathway 0.88
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (LNCaP RNA-seq) 0.88
Accurate annotation of human protein-coding small open reading frames 0.88
UBE3A-mediated regulation of imprinted genes and epigenome-wide marks in human neurons 0.87
Evaluation of RNA amplification and RNA-Seq library preparation protocols for spermatozoa RNA profiling 0.87
MicroRNA-125a-5p overexpression in human macrophages 0.87
Intron retention induced by microsatellite expansions as a disease biomarker. 0.86
Non-coding and coding transcriptional profiles are significantly altered in pediatric Retinoblastoma tumors 0.86
The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia 0.85
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia 0.85
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia [RNA-seq] 0.85
Androgen Receptor-regulated genes in prostate cancer cells 0.84
RNA-seq profiling identifies Androgen Receptor-regulated genes in prostate cancer cells 0.84
Transcriptomic analysis of acute mitochondrial pyruvate carrier inhibition using UK5099 in ABL prostate cancer cells 0.84
BACH2 in human plasma cell fate decision 0.84
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC [Total RNA-Seq] 0.84
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC 0.84
Gene expression by high-throughput sequencing of T47D-MTVL human breast cancer cells upon H1.4 knock-down and multiple H1 variants 0.84
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 0.84
Hematopoietic Stem and Progenitor Cells from Human Pluripotent Stem Cells via Transcription Factor Conversion of Hemogenic Endothelium 0.84
The stress granule transcriptome reveals principles of mRNA accumulation in stress granules. 0.83
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo [RNA-seq] 0.82
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo 0.82
Transcriptomic profiling of O-GlcNAcylated mRNA-protein complexes by using OG-CLAP in HeLa cells. 0.8
Domain-focused CRISPR-screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells 0.8
Integrative analysis identifies targetable CREB1/FoxA1 transcriptional co-regulation as a predictor of prostate cancer recurrence 0.79
Expression profile of HNF1A knockdown and overexpression in 22RV1 and LNCaP cells respectively 0.78
RNA-seq of primary patient AML samples 0.78
A histone H3.3 Lysine 36 Trimethylation Reader Connects Chromatin to Regulated Pre-mRNA Processing 0.78
Next Generation Sequencing Facilitates Quantitative Analysis of transcriptomes of human cord blood CD34+ cells treated with HDAC5 inhibitor 0.78
The Human Testis Cell Atlas via Single-cell RNA-seq 0.78
Systems-level analyses reveal a convergent pathway for progression of diffuse astrocytoma and potential role for resveratrol in delaying high-grade transformation 0.77
An siRNA screen identifies CHD4 as a target for epigenetic therapy 0.77
Luminal lncRNAs Regulation by ERα-controlled Enhancers in a Ligand-independent Manner in Breast Cancer Cells 0.76
ARS2 is a general suppressor of pervasive transcription [RNAseq] 0.76
mRNA expression levels in splenic human mononuclear cells of mock- and HIV-1-infected humanized mice 0.75
RNA sequencing of bone marrow CD34+ cells from myelodysplastic syndrome patients with and without SF3B1 mutation and from healthy controls 0.74
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates 0.74
Integrated epigenomic and transcriptomic profiling of terminal human erythropoiesis [TMCC2] 0.74
Hepatosplenic T cell lymphoma 0.74
Integrative Genomic and Transcriptomic Analysis Identified Candidate Genes Implicated in the Pathogenesis of Hepatosplenic T-cell Lymphoma 0.74
Dynamic 3D chromosomal landscapes in acute leukemia 0.74
Dynamic 3D chromosomal landscapes in acute leukemia [RNA-Seq] 0.74
FMRP-associated MOV10 facilitates and antagonizes miRNA-mediated regulation 0.74
Role of XRN2 ribonucleolytic activity in RNA metabolism 0.72
The effect of Abl kinases on non-small cell carcinoma global transcriptome 0.71
The conserved transcriptional landscapes in human spermatogenesis 0.71
Next Generation Sequencing Study of Circadian Changes in Transcriptome of Human Pineal Gland 0.7
Replication defective viral products exploit a cellular pro-survival mechanism to establish persistent infections 0.7
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 0.69
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 (RNA-seq data sets) 0.69
Transcriptomics profiles of patient-matched normal kidney and ccRCC pairs 0.68
An improved method for circular RNA purification that efficiently removes linear RNAs containing G-quadruplexes or structured 3’ ends 0.67
MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia. 0.67
Novel SF3B1 Deletion Mutations Result in Aberrant RNA Splicing in CLL Patients 0.67
CT Irradiation Induced Changes of Gene Expression within Peripheral Blood Cells 0.66
Patient-derived xenograft models of non-small cell lung cancer for evaluating targeted drug sensitivity and resistance 0.66
RNA sequencing data of whole blood cells of normal glucose tolerant (NGT) and gestational diabetes (GDM) pregnant women 0.65
4sU-seq of HFF exposed to salt and heat stress 0.65
The immediate impact of exoribonucleolysis on nuclear RNA processing, turnover and transcriptional control revealed by rapid depletion of DIS3, EXOSC10 or XRN2 from human cells 0.65
Gene expression in mature and immature human ES-derived beta cells, and sorted beta-cells from adult islets 0.65
Genome-wide analysis of the Integrator complex 0.64
Genome-wide analysis of the Integrator complex (HTS) 0.64
Comprehensive Transcriptome Analysis of Cerebral Cavernous Malformation Across Multiple Species and Genotypes 0.64
Gene expression profiling of human iPS cell-derived podocytes and sorted human adult podocytes 0.63
Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood 0.63
RNA-seq analysis of human KMT2A rearranged MV4;11 AML cell line treated with DOT1L and/or EZH2 inhibitor 0.63
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration 0.63
MondoA Links Muscle Lipid Accumulation and Insulin Resistance Driven by Nutrient Overload 0.62
Transcriptome profiling in primary human skeletal myotubes with MondoA knockdown 0.62
The circadian transcriptional landscape in primary human mammary epithelial cells 0.62
The LRF/ZBTB7A transcription factor is a BCL11A-independent repressor of fetal hemoglobin 0.62
ENCODE Cold Spring Harbor Labs Long RNA-seq 0.62
Luminal subtype-specific circRNAs in breast cancer cells by a novel tool for external data analysis. 0.62
siRNA-mediated silencing of ORAI3 in MDA-MB-468 breast cancer cells exposed to hypoxia 0.62
CD90 Identifies Adventitial Mesenchymal Progenitor Cells in Adult Humans 0.6
Transcriptional study of ARN8 cells treated with novel DHODH inhibitors 0.6
Novel Non-catalytic Substrate-selective p38α-specific MAPK Inhibitors with Endothelial-Stabilizing and Anti-inflammatory Activity 0.6
Gene expression and splicing alterations analyzed by high throughput RNA sequencing of chronic lymphocytic leukemia specimens 0.6
Modulation of SF3B1 causes global intron retention and downregulation of the B-cell receptor pathway in chronic lymphocytic leukemia 0.59
Strand-specific Dual RNA-seq of Bronchial Epithelial cells Infected with Influenza A/H3N2 Viruses Reveals Splicing of Gene Segment 6 and Novel Host-Virus Interactions 0.59
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 2: scRNA-seq) 0.59
UMI-count modeling and differential expression analysis for single-cell RNA sequencing 0.59
Mucosal Profiling of Pediatric-Onset Colitis and IBD Reveals Common Pathogenics and Therapeutic Pathways 0.59
Integrative analysis of RNA, translation and protein levels reveals distinct regulatory variation across humans 0.58
Mapping interactions for the TNIP2 hub protein 0.56
Transcriptome profiling of 5 human adenocarcinoma cell lines 0.55
4sUDRB-seq: measuring transcription elongation and initiation genomewide 0.55
Transcriptome sequencing of a large human family identifies the impact of rare non-coding variants 0.54
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 0.54
Gene expression of thyroid cancer cell lines 0.54
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability [RNA-Seq] 0.53
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability 0.53
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 0.53
Transcriptome-wide analysis links the short-term expression of the b isoforms of T-cell intracellular antigens to protective proteostasis-mediated survival and quiescence 0.52
ZRANB2 and SYF2 mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicin 0.52
RNA sequencing of mechanically strained NHEKs and control NHEKs 0.52
ZEB1 insufficiency causes corneal endothelial cell state transition and altered cellular processing 0.52
RNAseq of T-ALL upon long non coding rna purturbation 0.52
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 0.52
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 0.52
RNA sequencing of primary human platelets and in vitro cell lines 0.51
Transcriptomics analysis of gene expression in normal and METTL3 or WTAP deficient Human HeLa cells 0.51
Studying iPSCs from a hibernating mammal reveals molecular mechanisms of cold resistance in neural tissues 0.51
The Cushing's disease adipose gene expression profile reveals effects of long term glucocorticoids on adipose tissue lipid, protein and glucose metabolism 0.51
RNA-Seq identifies condition-specific biological signatures of ischemia-reperfusion injury in the human kidney 0.51
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 0.51
The effect of REST and its alternatively spliced transcript, REST-003, on breast cancer invasiveness 0.5
The ZZ-type zinc finger of ZZZ3 modulates the ATAC complex-mediated histone acetylation and gene activation 0.5
RNA-seq differential expression studies: more sequence, or more replication? 0.49
HEK293 Heat-shock experiment 0.49
Radiomic and gEnomic approaches for the enhanced DIagnosis of REnal Cancer (REDIRECt): A translational pilot study 0.48
RNA-Guided Human Gene Activation by Cas9/CRISPR-Based Engineered Transcription Factors 0.48
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs (expression) 0.48
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs 0.48
Charaterization of genetic alterations and gene expression signatures found in BCR-ABL inhibitor-resistant KCL-22 subpopulations and single clones 0.47
miR-155 plays a crucial role in ALS and is an immune therapeutic target [RNA-Seq] 0.47
Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice 0.47
CD86 regulates a pro-survival signal in myeloma cells 0.47
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells 0.47
A Druggable TCF4- and BRD4-dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm (RNA-Seq) 0.46
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [ESRP KD] 0.46
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent 0.46
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent (RNA-seq) 0.46
An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch Type Alopecia Areata, Totalis and Universalis 0.45
ERK potentiates transactivation and oncogenic function of ERG by phosphorylation induced dissociation of PRC2 complex 0.45
A Unique Epigenomic Landscape Defines Human Erythropoiesis 0.45
A Unique Epigenomic Landscape Defines Human Erythropoiesis (RNA-seq) 0.45
Comprehensive molecular phenotypic effects of the large deletion on chromosome 22q11.2 0.44
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 0.43
A Distinct Epigenetic Program Underlies the 1;7 Translocation in Myelodysplastic Syndromes (MDS) 0.43
Expression Analysis of dic(1;7)(q10;p10) in Myelodysplastic Syndromes (MDS) compared to control cohort and therapy-related Myeloid Neoplasms (t-MN) 0.43
Integrative classification of human coding and non-coding genes based on RNA metabolism profiles 0.43
The role of the Calcium-Sensing receptor in colorectal cancer 0.42
Frailty in middle age is associated with race-specific changes to the transcriptome. 0.42
Sequencing of freshly produced RNA following exposure of cells to DNA damage-inducing UV mimetic 4-hydroxyaminoquinolone (4-NQO) 0.42
RNA-seq analysis identifies different transcriptomic types and developmental trajectories of primary melanomas 0.41
Gene expression activation in CLL mediated by MSCs contact 0.4
Transcriptomics analysis of human jejunal enteroendocrine cells after vertical sleeve gastrectomy 0.4
Transcriptomics analysis of enteroendocrine cells following vertical sleeve gastrectomy 0.4
Clinker: visualizing fusion genes detected in RNA-seq data 0.39
LncPRESS1 is a p53-regulated lncRNA that safeguards pluripotency by disrupting SIRT6 mediated de-acetylation of histone H3K56 0.39
The Regulation of IFN Type I Pathway Related Genes RSAD2 and ETV7 Specifically Indicate Antibody-Mediated Rejection After Kidney Transplantation 0.39
Effect of PRDM11 depletion in U2932 cells 0.38
Integrated Multi-omic Analysis of Esthesioneuroblastomas Identifies Two Subgroups Linked to Cell Ontogeny 0.37
Novel Atherogenic Pathways from the Differential Transcriptiome Analysis of Diabetic Epicardial Adipose Tissue 0.37
Transcriptome analysis revealed impaired cAMP responsiveness in PHF21A-deficient human cells 0.37
Recurrent alterations of TNFAIP3 (A20) in T-cell large granular lymphocytic leukemia 0.37
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 0.36
Effects of a nutritional supplement in older individuals subject to ten days of complete bed rest. 0.36
Whole blood stabilization for the microfluidic isolation and molecular characterization of circulating tumor cells 0.36
Genome-wide discovery of human splicing branchpoints 0.36
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 0.36
EPCR Expression Defines the Most Primitive Subset of Human HSPC and Is Required for Their In Vivo Activity 0.35
RNA-seq of synchronized S phase or G2 phase cells treated with an ATR inhibitor 0.35
Therapy-induced hypoxia contributes to AML drug-resistance through BMX Kinase upregulation 0.35
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 0.35
An optimization system for isolating and sequencing of single human colon cancer cells 0.34
RNA Sequencing Analysis of villus tissues from unexplained recurrent spontaneous abortion patients and controls with induced abortions 0.34
Gene expression analysis in response to hypoxic pathway inhibition 0.34
KANK1 inhibits cell growth by inducing apoptosis though regulating CXXC5 in human malignant peripheral nerve sheath tumors 0.33
Suppression of NAF-1 in Breast Cancer Cells Reduces their Tumorigenicity by Interfering with Cellular Iron Distribution and Metabolism and Ensuing ROS Formation and Apoptosis 0.32
Enhancement of Human B Cell Differentiation and Function in Lymph Nodes by the TLR9 Agonist MGN1703 0.31
Genome-wide discovery of human splicing branchpoints [RNAse] 0.31
UV_24h_GRO-Seq 0.31
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors 0.3
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [TAV] 0.3
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques 0.3
Analysis of transcriptional differences after IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 0.29
Transcriptional analysis of ZIKV-infected Ifnar-/- and Ifnar+/- placentas and IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 0.29
Epigenetic reprogramming of melanoma cells by vitamin C treatment 0.29
Aberrant expression profile of lncRNA and mRNA in dilated cardiomyopathy by RNA-sequence 0.29
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 0.29
Single cell RNA sequencing reveals microglia-like cells in cerebrospinal fluid  during virologically suppressed HIV 0.29
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells (RNA-Seq) 0.28
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells 0.28
RNA transcriptome analysis of IRF1 and IRF3 knockout in immortalized primary hepatocytes infected with hepatitis A virus 0.28
Genomic deletion of malic enzyme 2 confers collateral lethality in pancreas cancer 0.28
Kidney compartment specific eQTL studies highlight causal genes and pathways for renal disease development 0.27
Specific molecular signatures underlie response to decitabine in CMML 0.27
Specific molecular signatures underlie response to decitabine in CMML [RNA-seq] 0.27
The Wnt/β-catenin and RAS-ERK Pathways were Activated in Tissues of Chemotherapy-Resistant Gastric Cancer PDX Tumor 0.27
Epigenomic plasticity enables human pancreatic alpha to beta cell reprogramming 0.27
Alterations of the MEK/ERK, BMP, and Wnt/b-catenin pathways detected in the blood of individuals with lymphatic malformations 0.24
Defective transcription elongation in a subset of cancers confers immunotherapy resistance 0.24
LKB1, Salt-Inducible Kinases, and MEF2C are linked dependencies in acute myeloid leukemia (RNA-Seq) 0.23
LKB1, Salt-Inducible Kinases, and MEF2C are linked dependencies in acute myeloid leukemia 0.23
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 0.23
Gene expression profile in breast cancer cells 0.23
The MEF2B Regulatory Network 0.23
The MEF2B Regulatory Network - RNA-seq data 0.23
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 0.23
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 0.23
Expression analysis of the TAF1 syndrome 0.23
HeLa transcriptome induction by IFN gamma and indoleamine 2,3-dioxygenase (IDO) 0.22
RNA sequencing of prostate cancer and normal tissue from African Americans and European Americans 0.22
Single-Cell Transcriptome Analysis of Lineage Diversity and Microenvironment in High-Grade Glioma 0.22
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. [RNA-Seq] 0.22
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. 0.22
Leucegene: ALL sequencing 0.21
Gene expression profile of calcified and normal tricuspid aortic valves by RNA sequencing. 0.21
Next Generation Sequencing Facilitates Quantitative Analysis of SW480 cells and HPSE-knockdown SW480 cells Transcriptomes 0.21
Gene expression analysis upon mtDNA depletion [RNA-seq] 0.2
Gene expression analysis upon mtDNA depletion 0.2
quanTIseq: quantifying immune contexture of human tumors 0.2
Transcriptome analysis of total RNA in human osteosarcoma cell line U2OS before and after inhibition of zinc finger protein ZNF768 0.2
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 0.19
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 0.19
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 [RNA-Seq] 0.18
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 0.18
Intrinsic Plasma Cell Differentiation Defects in BENTA Patient B cells 0.18
Exercise-induced transcriptome changes in skeletal muscle adapted to aerobic training 0.18
Insulin induced alterations in chromatin acetylation and transcriptome in triple negative breast cancer cells 0.18
Expression analysis of PC3 cells treated with scramble AON or AON directed against MBNL1 0.18
SF3B1 Degron knockdown RNA-seq 0.18
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML [RNA-Seq human] 0.16
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML 0.16
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of HSCe) 0.16
Antiviral and anti-inflammatory properties of novel anti-HIV candidate ABX464 promotes specifics RNA splicing while preserving cellular RNA integrity. 0.16
A monocyte gene expression signature in the early clinical course of Parkinson’s disease 0.16
Total RNA-Seq data from leukemic patients with complex structural variants 0.15
BRG1 governs Glucocorticoid Receptor interactions with chromatin and pioneer factors across the genome 0.15
The role of m6A/m-RNA methylation in stress response regulation 0.15
m6A/m-Seq of human B-lymphocyte cell lines from healthy controls and major depressive disorder patients 0.15
Transcriptome Analysis Reveals Distinct Responses to Physiologic versus Toxic Manganese Exposure in Human Neuroblastoma Cells 0.15
Gene expression profiling by RNA-seq of SW480 TGM2 knockdown cells 0.15
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation (RNA-Seq) 0.14
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation 0.14
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 KO] 0.14
Enhancer activation during EGF response 0.14
circNFIB suppresses lymphatic metastasis of pancreatic cancer 0.14
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 0.14
Gene expression of collecting duct carcinoma of the kidney 0.13
Modeling Human Cancer-induced Cachexia (Human) 0.13
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction. 0.13
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction [RNA-seq] 0.13
Non-IG Aberrations of FOXP1 in B-Cell Malignancies Lead to an Aberrant Expression of N-Truncated Isoforms of FOXP1 0.12
Transcriptome profiling (RNA-seq) of CREBBP+/+ and CREBBP+/- clones of U2932 DLBCL cell line 0.12
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) [RNA-seq] 0.12
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) 0.12
Stapled peptide inhibitors of RAB25 target context-specific phenotypes in cancer 0.11
Gene expression profiling in metabolically heterogeneous human lung tumors 0.11
Long non-coding RNA profiling of human lymphoid progenitors reveals transcriptional divergence of B cell and T cell lineages 0.11
ELAVL2-regulated transcriptional networks in human neurons link atlernative splicing, autism and human neocortical evolution 0.11
Illumina HiSeq Sequencing on Breast cancer PDX samples 0.11
ADAR1-editing in HeLa, p150-KO and ADAR1-KO transcriptomes 0.1
ADAR1-editing of cellular and measles virus-derived duplex RNA 0.1
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 0.1
Long non-coding RNAs are central regulators of the IL-1b-induced inflammatory response in human lung fibroblasts 0.1
JMJD1C is required for the survival of acute myeloid leukemia by functioning as a co-activator for key transcription factors 0.1
RNA expression analysis upon JMJD1C depletion 0.1
Identification of Tissue-Specific Protein-Coding and Noncoding Transcripts across 14 Human Tissues Using RNA-seq 0.1
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells [RNA-Seq] 0.1
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells 0.1
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 0.09
The effect of slow and rapid H2S production on the levels of LPS-induced proinflammatory mediators and transcription in different human cell cultures 0.09
5hmC and gene expression data in breast cancer cell lines treated with an antioxidant 0.09
Histone demethylase LSD1 is required for germinal center formation and BCL6 driven lymphomagenesis 0.08
Transcriptional changes in lymphoma cells induced by LSD1 depletion 0.08
Effect of BB608 on Gene Expression in HNSCC Cell Line 0.08
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 rescue] 0.08
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [Primary RNA-Seq] 0.08
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) 0.08
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) [RNA-seq] 0.08
Integration of ATAC-seq and RNA-seq Identifies Human Alpha Cell and Beta Cell Signature Genes 0.07
LED, a long non-coding RNA activator of enhancer RNAs, is hypermethylated in human cancers 0.06
Function and hormonal regulation of GATA3 in human first trimester placentation 0.06
An evolutionary recent IFN-IL-6-CEBP axis is linked to monocyte expansion and tuberculosis severity in humans. 0.06
A Phase II Study of Pomalidomide, Daily Low Dose Oral Cyclophosphamide, and Dexamethasone in Relapsed/Refractory Multiple Myeloma 0.06
RNA-seq analysis of differentiating human erythroblasts 0.05
Global Transcriptome Analyses of Mammalian Terminal Erythroid Differentiation 0.05
Hsa-miR-371a-5p and hsa-miR-518a-3p regulated genes in choriocarcinoma cells 0.05
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.04
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.04
Transcriptome analysis of BAP1 knockout and restoration 0.04
Expression profiles of restoration of BAP1 in a BAP1 deficient cell line 0.04
RNA sequencing and pathway analysis identify important pathways involved in hypertrichosis and intellectual disability in patients with Wiedemann-Steiner syndrome 0.04
Human Tfh cell RNA bulk sequencing 0.03
Longitudinal transcriptome profiling of post-treatment Lyme disease syndrome 0.02
A novel target of EZH1/2 for treatment of mantle cell lymphoma 0.02
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.02
Aberrant splicing in B-cell acute lymphoblastic leukemia [B-ALL] 0.02
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function 0.02
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function [RNAseq] 0.02
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures [RNA-Seq] 0.01
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures 0.01
Gene expression for surgically treated pancreatic cancer after one neoadjuvant vaccine dose 0.01
Osmostress induced changes of chromatin architecture and transcription in mammalian cells 0.01
Osmostress induced changes of chromatin architecture and transcription in mammalian cells [RNA-Seq, HiC] 0.01
Identification of an IL-1-induced gene expression pattern in AR+ PCa cells that mimics the molecular phenotype of AR- PCa cells 0.01
Transcriptomic profile of T cell acute lymphoblastic leukemia (T-ALL) cell from patients in CHCQMU 0.01
Studying the selectivity of a targeted small molecule degrading a hypoxia-associated non-coding RNA 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation